Lara E. KrebsAdvisor - Bioprocess Research and Development at Eli Lilly and CompanySpeaker
Agenda Sessions
Strategically Leveraging Impurity Challenge Studies: Accelerating & Streamlining Commercial mAb Development; Enhancing Regulatory Submissions
, 9:00amView Session